Trial Interactive has been designed by clinical professionals, for clinical professionals to support studies on a global scale. An extremely flexible and practical solution, Trial Interactive is consistently noted by clinical professionals for providing the most comprehensive yet intuitive features and work flows. As a secure, cloud-based solution, Trial Interactive enables real-time collaboration for both Sponsors and CROs. Whatever you need, our experienced staff will assist you through the process and provide fast, 24/7 support. Our platform includes the following modules:
With today's technology, centralized global access to TMF documentation is readily available to study teams and complies with regulatory authority requirements.
LMS or Learning Management Systems have widely been adopted to host training materials and streamline the global training of staff for companies.
The myTI application is a mobile extension of Trial Interactive, providing study teams with mobile document capture, real-time document work streams, and insights into completeness – anytime and anywhere.
A workspace for clinical teams to provide Sponsors, CROs, and Sites a place to share and author documentation to be used in the Clinical Trial and ultimately archived in the eTMF.
Trial Interactive's e-feasibility streamlines the global feasibility process for deciding which countries should be in a study based on the disease prevalence, access to patients, regulations, and more.
TransPerfect's global document management capabilities allow rapid scanning, coding, and indexing of development and commercialization documentation.
One of the many challenges in conducting clinical trials is the speed to completion and finalization of essential and regulatory documents by the investigative site personnel. Trial Interactive makes the process more efficient by integrating our Study Start-Up module with our eTMF.
Leverage your own historical data in combination with other public sources for a deep repository of investigator and site information around the world.